Evidence map›Paper›PMID 27737834›Full record

SynthesisBMJ (Clinical research ed.)2016

Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review.

Julian P T Higgins, Karla Soares-Weiser, José A López-López, Artemisia Kakourou, Katherine Chaplin, Hannah Christensen, Natasha K Martin, Jonathan A C Sterne, Arthur L Reingold

Erratum issued 9 registry-linked trialsOpen access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BMJ (Clinical research ed.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 9 registered trials, which are not on this map. Cited by 367 papers, 91 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
367citing papers in PubMed, 91 pooled it
18.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04373291 phase3completednot on this mapstarted 2020, after this paper: background citation

Using BCG Vaccine to Enhance Non-specific Protection of Health Care Workers During the COVID-19 Pandemic. A Randomized Controlled Multi-center Trial

TypeinterventionalSponsorBandim Health ProjectRan2020 to 2021Enrolled1,293ConditionsCOVID-19, Non-specific Effects of Vaccines, Morbidity, AbsenteeismArmsBCG-Denmark, Saline
NCT04383925 phase4completednot on this mapstarted 2020, after this paper: background citation

Randomized Trial Evaluating the Non-specific Effects of Different BCG Strains in Guinea-Bissau: Effects on Early-life Mortality and Morbidity

TypeinterventionalSponsorBandim Health ProjectRan2020 to 2022Enrolled16,390ConditionsDeath, Infant, Morbidity, InfantArmsBCG-Japan, BCG-Russia
NCT04534803 phase3withdrawnnot on this mapstarted 2021, after this paper: background citation

Bacillus Calmette-Guerin Against Covid-19 for Prevention and Amelioration of Severity Trial

TypeinterventionalSponsorHarvard Medical School (HMS and HSDM)Ran2021 to 2022Enrolled0ConditionsCovid19ArmsBCG Vaccine, Placebo
NCT04632537 phase3withdrawnnot on this mapstarted 2020, after this paper: background citation

Novel Use of an Existing Vaccine (BCG) Alliance: The NUEVA Trial

TypeinterventionalSponsorHenry M. Jackson Foundation for the Advancement of Military MedicineRan2020 to 2021Enrolled0ConditionsCOVID-19ArmsTice® BCG (for intravesical use) BCG LIVE strain of the BCG (Merck) vaccine, Preservative-free saline
NCT04641858 phase4completednot on this mapstarted 2020, after this paper: background citation

BCG Vaccine to Reduce Unplanned Absenteeism Due to Illness of Health Care Workers During the COVID-19 Pandemic. A Multi-center Randomised Controlled Trial (BCG-COVID-RCT)

TypeinterventionalSponsorUniversity of Southern DenmarkRan2020 to 2022Enrolled668ConditionsCovid19, Morbidity, AbsenteeismArmsBCG-Denmark, Saline
NCT04658680 phase4active not recruitingnot on this mapstarted 2021, after this paper: background citation

Can BCG Vaccination at First Health-facility Contact Reduce Early Infant Mortality? A Cluster Randomised Trial

TypeinterventionalSponsorBandim Health ProjectRan2021 to 2026Enrolled22,800ConditionsInfant Mortality, BCGArmsBCG vaccination at first health facility contact
NCT04938323 phase2 / phase3withdrawnnot on this mapstarted 2022, after this paper: background citation

Prevention of Acute Respiratory Infection in Taiwanese Institutionalized Elderly (PARITIE)

TypeinterventionalSponsorHarvard Medical School (HMS and HSDM)Ran2022 to 2022Enrolled0ConditionsAcute Respiratory InfectionArmsBCG Vaccine, Placebo
NCT05507671 phase3active not recruitingnot on this mapstarted 2021, after this paper: background citation

The Role of the Bacillus Calmette-Guérin Vaccine (BCG) in the Clinical Evolution of COVID-19 and in the Efficacy of Anti-SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) Vaccines

TypeinterventionalSponsorOswaldo Cruz FoundationRan2021 to 2025Enrolled556ConditionsCOVID-19ArmsBCG (Bacillus Calmette-Guérin) vaccine, Placebo
NCT07005726 phase4enrolling by invitationnot on this mapstarted 2025, after this paper: background citation

BCG2-DTP3: Providing BCG Revaccination With the Third Dose of Diphtheria-tetanus-pertussis Vaccine to Improve Female Survival in Africa

TypeinterventionalSponsorBandim Health ProjectRan2025 to 2030Enrolled6,000ConditionsInfant Morbidity, Infant Mortality, Non-Specific Effects of Vaccines, BCGArmsBCG Vaccine
3 · Its place in the literature

Who cites it

367 citing papers in PubMed, 91 syntheses or guidelines pooled it, 606 citations in OpenAlex.

  1. Pooled it
  2. Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-positive advanced or metastatic gastric or gastroesophageal cancer: a meta-analysis of single-arm trials.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Pooled it
  3. Whole-brain radiotherapy with simultaneous integrated boost in treatment of patients with brain metastases: a systematic review and meta-analysis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Pooled it
  18. Pooled it
  19. Pooled it
  20. Pooled it

307 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Julian P T HigginsSchool of Social and Community Medicine, University of Bristol, Bristol BS8 2PS, UK julian.higgins@bristol.ac.uk.
Karla Soares-WeiserCochrane, St Albans House, London SW1Y 4QX, UK.
José A López-LópezSchool of Social and Community Medicine, University of Bristol, Bristol BS8 2PS, UK.
Artemisia KakourouDepartment of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.
Katherine ChaplinSchool of Social and Community Medicine, University of Bristol, Bristol BS8 2PS, UK.
Hannah ChristensenSchool of Social and Community Medicine, University of Bristol, Bristol BS8 2PS, UK.
Natasha K MartinSchool of Social and Community Medicine, University of Bristol, Bristol BS8 2PS, UK Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
Jonathan A C SterneSchool of Social and Community Medicine, University of Bristol, Bristol BS8 2PS, UK.
Arthur L ReingoldDivision of Epidemiology, School of Public Health, University of California, Berkeley, CA 94720-7358, USA.
University of Bristol · GBCochrane · GBUniversity of California, Berkeley · USUniversity of Ioannina · GRUniversity of London · GB

Funding

Modeling Structural HIV Determinants in Substance Users and related populationsR01DA037773 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MARTIN, NATASHA, STRATHDEE, STEFFANIE A. · 2015 to 2017
$1.4M
Department of Health PDF-2011-04-049Department of Health PDF-2012-05-245NIDA NIH HHS R01 DA037773
6 · The paper itself

Abstract

objectivesTo evaluate the effects on non-specific and all cause mortality, in children under 5, of Bacillus Calmette-Guérin (BCG), diphtheria-tetanus-pertussis (DTP), and standard titre measles containing vaccines (MCV); to examine internal validity of the studies; and to examine any modifying effects of sex, age, vaccine sequence, and co-administration of vitamin A.

designSystematic review, including assessment of risk of bias, and meta-analyses of similar studies. STUDY ELIGIBILITY CRITERIA: Clinical trials, cohort studies, and case-control studies of the effects on mortality of BCG, whole cell DTP, and standard titre MCV in children under 5. DATA SOURCES: Searches of Medline, Embase, Global Index Medicus, and the WHO International Clinical Trials Registry Platform, supplemented by contact with experts in the field. To avoid overlap in children studied across the included articles, findings from non-overlapping birth cohorts were identified.

resultsResults from 34 birth cohorts were identified. Most evidence was from observational studies, with some from short term clinical trials. Most studies reported on all cause (rather than non-specific) mortality. Receipt of BCG vaccine was associated with a reduction in all cause mortality: the average relative risks were 0.70 (95% confidence interval 0.49 to 1.01) from five clinical trials and 0.47 (0.32 to 0.69) from nine observational studies at high risk of bias. Receipt of DTP (almost always with oral polio vaccine) was associated with a possible increase in all cause mortality on average (relative risk 1.38, 0.92 to 2.08) from 10 studies at high risk of bias; this effect seemed stronger in girls than in boys. Receipt of standard titre MCV was associated with a reduction in all cause mortality (relative risks 0.74 (0.51 to 1.07) from four clinical trials and 0.51 (0.42 to 0.63) from 18 observational studies at high risk of bias); this effect seemed stronger in girls than in boys. Seven observational studies, assessed as being at high risk of bias, have compared sequences of vaccines; results of a subset of these suggest that administering DTP with or after MCV may be associated with higher mortality than administering it before MCV.

conclusionsEvidence suggests that receipt of BCG and MCV reduce overall mortality by more than would be expected through their effects on the diseases they prevent, and receipt of DTP may be associated with an increase in all cause mortality. Although efforts should be made to ensure that all children are immunised on schedule with BCG, DTP, and MCV, randomised trials are needed to compare the effects of different sequences.

Indexed as

BCG VaccineChildChild, PreschoolDiphtheriaDiphtheria-Tetanus-Pertussis VaccineEvidence-Based MedicineFemaleHumansImmunization ScheduleInfantMaleMeaslesMeasles VaccineMortalityTetanusTuberculosisBCG VaccineDiphtheria-Tetanus-Pertussis VaccineMeasles Vaccine

Identifiers

PMID27737834
PMCPMC5063034
OpenAlexW2529875271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

and 3 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.